Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the
value_type as 'ranked' since this provides a very robust analysis method.
intercation map as 'high confidence'
network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2301 to 2350 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2301\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NMNAT3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nicotinamide nucleotide adenylyltransferase 3; pyridine nucleotide adenylyltransferase 3. [source:refseq;acc:nm\_178177]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.392\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.498\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00509\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2302\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HMGCS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hydroxymethylglutaryl-coa synthase, mitochondrial precursor (ec 2.3.3.10) (hmg-coa synthase) (3-hydroxy-3-methylglutaryl coenzyme a synthase). [source:swissprot;acc:p54868]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
191.567\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
192.542\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2303\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HMGCR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3-hydroxy-3-methylglutaryl-coenzyme a reductase (ec 1.1.1.34) (hmg-coa reductase). [source:swissprot;acc:p04035]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2304\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HMGCS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
hydroxymethylglutaryl-coa synthase, cytoplasmic (ec 2.3.3.10) (hmg-coa synthase) (3-hydroxy-3-methylglutaryl coenzyme a synthase). [source:swissprot;acc:q01581]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2305\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALDH18A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
delta 1-pyrroline-5-carboxylate synthetase (p5cs) [includes: glutamate 5-kinase (ec 2.7.2.11) (gamma-glutamyl kinase) (gk); gamma-glutamyl phosphate reductase (gpr) (ec 1.2.1.41) (glutamate-5-semialdehyde dehydrogenase) (glutamyl-gamma-semialdehyde dehydrogenase)]. [source:swissprot;acc:p54886]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.392\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.498\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2306\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACAT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
acetyl-coa acetyltransferase, mitochondrial precursor (ec 2.3.1.9) (acetoacetyl-coa thiolase) (t2). [source:swissprot;acc:p24752]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.571\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
192.544\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00508\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2307\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAR2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-alpha regulatory chain. [source:swissprot;acc:p13861]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.554\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.467\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00507\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein kinase pkx1 (ec 2.7.1.-). [source:swissprot;acc:p51817]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.543\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.459\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00505\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2309\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKACG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp-dependent protein kinase, gamma-catalytic subunit (ec 2.7.1.37) (pka c-gamma). [source:swissprot;acc:p22612]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.542\vspace{3pt}}&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2310\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.617\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.529\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2311\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKACB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp-dependent protein kinase, beta-catalytic subunit (ec 2.7.1.37) (pka c-beta). [source:swissprot;acc:p22694]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.542\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.459\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2312\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKACA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp-dependent protein kinase, alpha-catalytic subunit (ec 2.7.1.37) (pka c-alpha). [source:swissprot;acc:p17612]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2313\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRKAR2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
camp-dependent protein kinase type ii-beta regulatory chain. [source:swissprot;acc:p31323]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.449\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00504\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2314\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBE2D2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 2 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 2). [source:swissprot;acc:p51669]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.743\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
195.708\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00496\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2315\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACACB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
acetyl-coa carboxylase 2 (ec 6.4.1.2) (acc-beta) [includes: biotin carboxylase (ec 6.3.4.14)]. [source:swissprot;acc:o00763]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.825\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
195.787\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00494\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2316\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.311\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00493\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2317\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPP6C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 6 (ec 3.1.3.16) (pp6). [source:swissprot;acc:o00743]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
194.834\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
195.794\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2318\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SAPS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sporulation-induced transcript 4-associated protein. [source:refseq;acc:nm\_018312]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2319\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ACACA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
acetyl-coa carboxylase 1 (ec 6.4.1.2) (acc-alpha) [includes: biotin carboxylase (ec 6.3.4.14)]. [source:swissprot;acc:q13085]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
195.8\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00492\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2320\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAD54L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.292\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.218\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2321\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tetratricopeptide repeat protein 4 (my044 protein). [source:swissprot;acc:o95801]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.909\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.925\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00485\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2322\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PDSS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
trans-prenyltransferase; polyprenyl pyrophosphate synthetase. [source:refseq;acc:nm\_014317]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
236.023\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.905\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00476\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2323\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
asparaginyl-trna synthetase, cytoplasmic (ec 6.1.1.22) (asparagine-- trna ligase) (asnrs). [source:swissprot;acc:o43776]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
193.691\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2324\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proteasome subunit beta type 1 (ec 3.4.25.1) (proteasome component c5) (macropain subunit c5) (multicatalytic endopeptidase complex subunit c5) (proteasome gamma chain). [source:swissprot;acc:p20618]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.129\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.129\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00474\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2325\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTFMT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
methionyl-trna formyltransferase, mitochondrial precursor (ec 2.1.2.9) (mtfmt). [source:swissprot;acc:q96dp5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.728\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.685\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00473\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2326\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAP2K4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.076\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00468\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2327\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s protease regulatory subunit 6b (mip224) (mb67 interacting protein) (tat-binding protein-7) (tbp-7). [source:swissprot;acc:p43686]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.426\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00466\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2328\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
REXO4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
xpmc2 prevents mitotic catastrophe 2 homolog; xenopus prevents mitotic catastrophe 2 homolog. [source:refseq;acc:nm\_020385]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.326\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.357\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00465\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2329\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMD13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 13 (26s proteasome regulatory subunit s11) (26s proteasome regulatory subunit p40.5). [source:swissprot;acc:q9unm6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.116\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00462\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2330\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FARSB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase beta chain (ec 6.1.1.20) (phenylalanine-- trna ligase beta chain) (phers) (hspc173). [source:swissprot;acc:q9nsd9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.213\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.235\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00459\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2331\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MIZF\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mbd2 (methyl-cpg-binding protein)-interacting zinc finger protein. [source:refseq;acc:nm\_015517]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.258\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
230.294\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00452\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2332\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TMOD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
skeletal muscle tropomodulin (sk-tmod) (tropomodulin 4). [source:swissprot;acc:q9nzq9]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TMOD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitous tropomodulin (u-tmod) (tropomodulin 3). [source:swissprot;acc:q9nyl9]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TMOD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tropomodulin 1 (erythrocyte tropomodulin) (e-tmod). [source:swissprot;acc:p28289]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNX9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sorting nexin 9 (sh3 and px domain-containing protein 1) (sdp1 protein). [source:swissprot;acc:q9y5x1]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TMOD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuronal tropomodulin (n-tmod) (tropomodulin 2). [source:swissprot;acc:q9nzr1]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2337\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLX2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein dlx-2. [source:swissprot;acc:q07687]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2338\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLX5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein dlx-5. [source:swissprot;acc:p56178]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2339\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MPPED2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fetal brain protein 239 (239fb). [source:swissprot;acc:q15777]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DLX3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
homeobox protein dlx-3. [source:swissprot;acc:o60479]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TNK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
activated p21cdc42hs kinase. [source:refseq;acc:nm\_005781]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAP3K7IP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 7 interacting protein 2 isoform 1; tak1-binding protein 2. [source:refseq;acc:nm\_015093]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycine cleavage system h protein, mitochondrial precursor. [source:swissprot;acc:p23434]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.222\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00451\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DAGLB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kccr13l. [source:refseq;acc:nm\_139179]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.878\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.893\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0045\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAD51\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna repair protein rad51 homolog 1 (hrad51) (hsrad51). [source:swissprot;acc:q06609]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek1 (ec 2.7.1.37) (nima-related protein kinase 1) (ny-ren-55 antigen). [source:swissprot;acc:q96py6]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.057\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00448\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEK3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek3 (ec 2.7.1.37) (nima-related protein kinase 3) (hspk 36). [source:swissprot;acc:p51956]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GAPDH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glyceraldehyde 3-phosphate dehydrogenase, liver (ec 1.2.1.12) (gapdh). [source:swissprot;acc:p04406]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FBLN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fibulin-1 precursor. [source:swissprot;acc:p23142]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
192.348\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
191.503\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00441\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CNDP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytosolic nonspecific dipeptidase (glutamate carboxypeptidase-like protein 1). [source:swissprot;acc:q96kp4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.733\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00439\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/